In 1976, Sothema, a visionary family-owned pharmaceutical company in Morocco, embarked on a journey that would redefine the pharmaceutical landscape in the country. Founded by the Tazi family, the company initially started with a single production facility. Over the next several decades, Sothema expanded its network of facilities, demonstrating a commitment to providing accessible, high-quality pharmaceutical products across Morocco. By 2020, Sothema had already established itself as a significant player in the pharmaceutical sector with multiple production sites and a diverse product portfolio. However, the onset of the COVID-19 pandemic presented an unprecedented challenge. The crisis not only tested the resilience of Sothema’s infrastructure but also the strategic acumen of its leadership. By examining the company’s strategic decisions and performance, you will identify key factors contributing 2 to Sothema’s resilience and provide recommendations for future growth and stability in the ever-evolving pharmaceutical landscape.